Excellence in the market is built on trust and transparency.
The Ljubljana Stock Exchange award for Stock of the Year is a confirmation that we are on the right path. Thank you to the Salus team and all partners who help shape our success.
We are proud to partner with Oncopeptides to expand access to Pepaxti® across Central and Eastern Europe. A targeted therapy for patients with multiple myeloma ...
We recently had the pleasure of hosting a remarkable group of students at Salus Group. They competed in the 2026 CFA Research Challenge against 1,100+ ...